Why Is Buffett Buying Verisign?
Warren Buffett has spent 2024 stockpiling cash, even going so…
Sell
50
VREX Quote, Financials, Valuation and Earnings
Last price:
$14.47
Seasonality move
:
-2.41%
Day range:
$14.64 - $15.26
52-week range:
$10.19 - $21.06
Dividend yield:
0%
P/E ratio:
17.52x
P/S ratio:
0.75x
P/B ratio:
1.14x
Volume:
340.4K
Avg. volume:
710.6K
1-year change:
-28.09%
Market cap:
$609.1M
Revenue:
$811M
EPS (TTM):
-$1.17
Analysts' Opinion
-
Consensus RatingVarex Imaging has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Varex Imaging has an estimated upside of 49.8% from its current price of $14.82.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $14.82.
Fair Value
-
According to the consensus of 0 analysts, Varex Imaging has 49.8% upside to fair value with a price target of -- per share.
VREX vs. S&P 500
-
Over the past 5 trading days, Varex Imaging has overperformed the S&P 500 by 2.37% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Varex Imaging does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Varex Imaging revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Varex Imaging reported revenues of $205.7M.
Earnings Growth
-
Varex Imaging earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Varex Imaging reported earnings per share of -$1.22.
Enterprise value:
866.1M
EV / Invested capital:
0.87x
Price / LTM sales:
0.75x
EV / EBIT:
27.24x
EV / Revenue:
1.07x
PEG ratio (5yr expected):
0.70x
EV / Free cash flow:
42.46x
Price / Operating cash flow:
29.80x
Enterprise value / EBITDA:
13.77x
Gross Profit (TTM):
$256.9M
Return On Assets:
-3.84%
Net Income Margin (TTM):
-5.88%
Return On Equity:
-8.23%
Return On Invested Capital:
-4.66%
Operating Margin:
5.3%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $859.4M | $893.4M | $811M | $227.4M | $205.7M | |
| Gross Profit | $283.5M | $290.3M | $256.9M | $78M | $67.1M | |
| Operating Income | $88.2M | $77.1M | $32.1M | $24.3M | $10.9M | |
| EBITDA | $114.5M | $91.2M | $62.9M | $16.3M | $16M | |
| Diluted EPS | $0.73 | $1.05 | -$1.17 | $0.66 | -$1.22 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $522M | $554.2M | $609.9M | $658.3M | $649.9M | |
| Total Assets | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | |
| Current Liabilities | $160.6M | $166.6M | $173.1M | $162.8M | $195.9M | |
| Total Liabilities | $673.7M | $651M | $637.7M | $668.6M | $667.8M | |
| Total Equity | $465.8M | $496.5M | $546.7M | $581M | $549.2M | |
| Total Debt | $455.3M | $434.5M | $414.4M | $442.6M | $443.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $16.9M | $108.4M | $47.3M | $47.1M | $25.9M | |
| Cash From Investing | -$48.4M | -$44.9M | -$27.5M | -$14.6M | -$14M | |
| Cash From Financing | -$23.8M | -$200K | -$3.3M | $1.4M | $800K | |
| Free Cash Flow | -$4.4M | $87.7M | $20.4M | $41.7M | $19.9M | |
VREX
Sector
Market Cap
$609.1M
$45.9M
Price % of 52-Week High
70.37%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-28.09%
-32.15%
Beta (5-Year)
0.603
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$14.60
200-day SMA
Buy
Level
$14.43
Bollinger Bands (100)
Buy
Level
11.34 - 14.86
Chaikin Money Flow
Buy
Level
3.5M
20-day SMA
Sell
Level
$15.33
Relative Strength Index (RSI14)
Sell
Level
48.24
ADX Line
Buy
Level
24.21
Williams %R
Neutral
Level
-63.7647
50-day SMA
Buy
Level
$14.55
MACD (12, 26)
Sell
Level
-0.06
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Sell
Level
-580.2K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.7214)
Sell
CA Score
(Annual)
Level (-0.3338)
Buy
Beneish M-Score
(Annual)
Level (-2.8994)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.6858)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
Stock Forecast FAQ
In the current month, VREX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VREX average analyst price target in the past 3 months is --.
-
Where Will Varex Imaging Stock Be In 1 Year?
According to analysts, the consensus estimate is that Varex Imaging share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Varex Imaging?
Analysts are divided on their view about Varex Imaging share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Varex Imaging is a Sell and believe this share price will drop from its current level to --.
-
What Is Varex Imaging's Price Target?
The price target for Varex Imaging over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VREX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Varex Imaging is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of VREX?
You can purchase shares of Varex Imaging via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Varex Imaging shares.
-
What Is The Varex Imaging Share Price Today?
Varex Imaging was last trading at $14.47 per share. This represents the most recent stock quote for Varex Imaging. Yesterday, Varex Imaging closed at $14.82 per share.
-
How To Buy Varex Imaging Stock Online?
In order to purchase Varex Imaging stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Microsoft an Undervalued Growth Stock to Buy?
Tech giant Microsoft (NASDAQ:MSFT) has been one of the biggest…
Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 30
Lemonade [LMND] is down 1.95% over the past day.
Sell
50
TSLL alert for Dec 30
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.67% over the past day.
Buy
63
SMLR alert for Dec 30
Semler Scientific [SMLR] is down 8.11% over the past day.
